These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 21811629)
1. Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα. Steinert G; Oancea C; Roos J; Hagemeyer H; Maier T; Ruthardt M; Puccetti E PLoS One; 2011; 6(7):e22540. PubMed ID: 21811629 [TBL] [Abstract][Full Text] [Related]
2. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077 [TBL] [Abstract][Full Text] [Related]
3. Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells. Zheng X; Beissert T; Kukoc-Zivojnov N; Puccetti E; Altschmied J; Strolz C; Boehrer S; Gul H; Schneider O; Ottmann OG; Hoelzer D; Henschler R; Ruthardt M Blood; 2004 May; 103(9):3535-43. PubMed ID: 14739224 [TBL] [Abstract][Full Text] [Related]
4. Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides. Beez S; Demmer P; Puccetti E PLoS One; 2012; 7(11):e48636. PubMed ID: 23152790 [TBL] [Abstract][Full Text] [Related]
5. Cooperation between constitutively activated c-Kit signaling and leukemogenic transcription factors in the determination of the leukemic phenotype in murine hematopoietic stem cells. Zheng X; Oancea C; Henschler R; Ruthardt M Int J Oncol; 2009 Jun; 34(6):1521-31. PubMed ID: 19424569 [TBL] [Abstract][Full Text] [Related]
6. AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway. Zhang Y; Wang J; Wheat J; Chen X; Jin S; Sadrzadeh H; Fathi AT; Peterson RT; Kung AL; Sweetser DA; Yeh JR Blood; 2013 Jun; 121(24):4906-16. PubMed ID: 23645839 [TBL] [Abstract][Full Text] [Related]
7. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha. Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608 [TBL] [Abstract][Full Text] [Related]
8. Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells. Romanski A; Schwarz K; Keller M; Wietbrauk S; Vogel A; Roos J; Oancea C; Brill B; Krämer OH; Serve H; Ruthardt M; Bug G Cell Cycle; 2012 Sep; 11(17):3219-26. PubMed ID: 22895185 [TBL] [Abstract][Full Text] [Related]
9. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation. Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413 [TBL] [Abstract][Full Text] [Related]
10. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Wang Y; Krivtsov AV; Sinha AU; North TE; Goessling W; Feng Z; Zon LI; Armstrong SA Science; 2010 Mar; 327(5973):1650-3. PubMed ID: 20339075 [TBL] [Abstract][Full Text] [Related]
11. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells. Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC. Rice KL; Hormaeche I; Doulatov S; Flatow JM; Grimwade D; Mills KI; Leiva M; Ablain J; Ambardekar C; McConnell MJ; Dick JE; Licht JD Blood; 2009 Dec; 114(27):5499-511. PubMed ID: 19855079 [TBL] [Abstract][Full Text] [Related]
13. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. Gao XN; Lin J; Ning QY; Gao L; Yao YS; Zhou JH; Li YH; Wang LL; Yu L PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536 [TBL] [Abstract][Full Text] [Related]
14. Eya2, a Target Activated by Plzf, Is Critical for Ono R; Masuya M; Ishii S; Katayama N; Nosaka T Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638 [TBL] [Abstract][Full Text] [Related]
16. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding. Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes. Du C; Redner RL; Cooke MP; Lavau C Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747 [TBL] [Abstract][Full Text] [Related]
18. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Perry JM; He XC; Sugimura R; Grindley JC; Haug JS; Ding S; Li L Genes Dev; 2011 Sep; 25(18):1928-42. PubMed ID: 21890648 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752 [TBL] [Abstract][Full Text] [Related]
20. The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac. Tai WP; Hu PJ; Wu J; Lin XC Tumori; 2014; 100(1):97-101. PubMed ID: 24675499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]